Search
for

    Sort by

    Research 571–600 of 1000+

    1. Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase BJU international · 2009 · 29 citations
    2. Estimating the Contribution of the Prostate to Blood Dihydrotestosterone 2003 · 28 citations
    3. Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer Journal of the American Heart Association · 2021 · 8 citations
    4. Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents. Revista chilena de nutrición · 2017 · 3 citations
    5. Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride Cureus · 2025 · 2 citations
    6. Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality The International Journal of Medical Science and Health Research · 2024 · 1 citations
    7. Androgen receptor-mediated gene activation in prostate cancer cells UEF eRepo (University of Eastern Finland) · 2010 · 1 citations
    8. Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial The Journal of Urology · 2017
    9. Konvergentna validacija farmakoekonomskih aspekata terapije benigne hiperplazije prostate u Crnoj Gori National Repository of Dissertations in Serbia · 2016
    10. Faculty Opinions recommendation of Screening for prostate cancer. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2013
    11. 1452 DETECTION RATE OF CLINICALLY INSIGNIFICANT PROSTATE CANCER INCREASES WITH REPEATING PROSTATE BIOPSIES The Journal of Urology · 2012
    12. Paradigm Shift in the Concept of Hormonal Milieu of Prostate Cancer InTech eBooks · 2011
    13. S3 SERUM TRIGLYCERIDE CONCENTRATION AND RISK OF PROSTATE CANCER: A PROSPECTIVE MULTICENTER STUDY European Urology Supplements · 2010
    14. Estudio clínico-patológico sobre el cáncer de próstata incidental en pacientes intervenidos bajo el supuesto diagnóstico de HBP sintomática Actas Urológicas Españolas · 2006
    15. Tratamientos fitoterapeúticos para la hipertrofia benigna de próstata: serenoa repens Metas de Enfermería · 2005
    16. Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer Urology · 2009 · 153 citations
    17. 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia International Journal of Cancer · 2006 · 57 citations
    18. Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer International Journal of Biological Sciences · 2014 · 23 citations
    19. Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behavior Journal of Ethnopharmacology · 2014 · 19 citations
    20. In vitro [7-3H]-testosterone metabolism by the rat ventral prostate—Effect of some exogenous compounds Journal of Steroid Biochemistry · 1975 · 12 citations
    21. Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment F1000Research · 2021 · 8 citations
    22. Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study British Journal of Cancer · 2022 · 4 citations
    23. Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study Cancer Causes & Control · 2017 · 4 citations
    24. Modulation of the canonical Wnt activity by androgen signaling in prostate epithelial basal stem cells bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 2 citations
    25. Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2 Research Square (Research Square) · 2021 · 1 citations
    26. Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer Cancers · 2024
    27. Re: Association of Treatment with 5α-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate Cancer The Journal of Urology · 2019
    28. Alopecia androgénica como factor predictor de hiperplasia benigna de próstata Universidad Privada Antenor Orrego · 2018
    29. Topical Application of Thermobalancing Therapy Enabled by Therapeutic Device Treats Enlarged Prostate and Improves Men's Quality of Life; New Opportunity in BPH Treatment Journal of Urology and Nephrology Open Access · 2016
    30. 342 COMPARISON OF THE INCIDENCE OF SECONDARY CANCERS AFTER IMRT, BRACHYTHERAPY AND SURGERY FOR THE TREATMENT OF PROSTATE CANCER The Journal of Urology · 2012